Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT02222948 · TERMINATED
Trial details
- NCT number
- NCT02222948
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-04-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.